If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Liliana Devizzi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 56 Similar Profiles
Hodgkin Disease Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Marginal Zone B-Cell Lymphoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Survival Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

  • 3658 Citations
  • 27 h-Index
  • 62 Article
  • 2 Letter

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma

Dodero, A., Guidetti, A., Tucci, A., Barretta, F., Novo, M., Devizzi, L., Re, A., Passi, A., Pellegrinelli, A., Pruneri, G., Miceli, R., Testi, A., Pennisi, M., Di Chio, M. C., Matteucci, P., Carniti, C., Facchetti, F., Rossi, G. & Corradini, P., Apr 1 2019, In : Leukemia. 33, 4, p. 1047-1051 5 p.

Research output: Contribution to journalLetter

Open Access

Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience

Marangon, M., Stefoni, V., Castellino, A., Visco, C., Tani, M., Cox, M. C., Marasca, R., Tecchio, C., Devizzi, L., Monaco, F., Romano, A., Rusconi, C., Rigacci, L., Castellino, C., Gaudio, F., Argnani, L. & Zinzani, P. L., Jul 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 7, p. e321-e323

Research output: Contribution to journalArticle

Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice

Broccoli, A., Casadei, B., Chiappella, A., Visco, C., Tani, M., Cascavilla, N., Conconi, A., Balzarotti, M., Cox, M. C., Marino, D., Goldaniga, M. C., Marasca, R., Tecchio, C., Patti, C., Musuraca, G., Devizzi, L., Monaco, F., Romano, A., Fama, A., Zancanella, M. & 6 others, Paolini, R., Rigacci, L., Castellino, C., Gaudio, F., Argnani, L. & Zinzani, P. L., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Multicenter Studies
Retrospective Studies
Non-Hodgkin's Lymphoma
Therapeutics

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial

Bruna, R., Benedetti, F., Boccomini, C., Patti, C., Barbui, A. M., Pulsoni, A., Musso, M., Liberati, A. M., Gini, G., Castellino, C., Rossini, F., Ciceri, F., Rota-Scalabrini, D., Stelitano, C., Di Raimondo, F., Tucci, A., Devizzi, L., Zoli, V., Zallio, F., Narni, F. & 15 others, Dondi, A., Parvis, G., Semenzato, G., Lanza, F., Perrone, T., Angrilli, F., Billio, A., Gueli, A., Mantoan, B., Rambaldi, A., Massimo Gianni, A., Corradini, P., Passera, R., Ladetto, M. & Tarella, C., Jan 1 2019, In : Haematologica. 104, 11, p. 2241-2248 8 p.

Research output: Contribution to journalArticle

Open Access
Follicular Lymphoma
Immunotherapy
Recurrence
Survival
Drug Therapy

High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO

Avivi, I., Arcaini, L., Ferretti, V. V., Boumendil, A., Finel, H., Milone, G., Zaja, F., Liliana, D., Musso, M., Didier, B., Bachy, E., Wattad, M., Nicolas-Virelizier, E., Gramatzki, M., Bourhis, J-H., Caillot, D., Haenel, A., Held, G., Thieblemont, C., Jindra, P. & 10 others, Pohlreich, D., Guilhot, F., Kroschinsky, F., Wahlin, B., Scheid, C., Ifrah, N., Berthou, C., Dreger, P., Montoto, S. & Conconi, A., Sep 2018, In : British Journal of Haematology. 182, 6, p. 807-815 9 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Lymphoma
Retrospective Studies
Therapeutics
Disease-Free Survival